drugset / Trial / NCT01908764

Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery

NCT01908764

Phase 1 Withdrawn Alcon Research
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to describe the pharmacokinetics of AL-60371 otic suspension following two posologies of bilateral ototopical doses in pediatric subjects immediately after bilateral tympanostomy tube surgery.

Timeline

Start
2014-11
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Finafloxacin Small molecule 0.2 ml Topical
Subject Finafloxacin Small molecule 4 unknown Topical

Indications